<http://www.wikidata.org/entity/statement/Q64710673-EC449AD4-B8EE-4343-9056-18A06A9535F2>	<http://wikiba.se/ontology#rank>	<http://wikiba.se/ontology#NormalRank> .
<http://www.wikidata.org/entity/statement/Q64710673-EC449AD4-B8EE-4343-9056-18A06A9535F2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#BestRank> .
<http://www.wikidata.org/entity/statement/Q64710673-EC449AD4-B8EE-4343-9056-18A06A9535F2>	<http://www.wikidata.org/prop/statement/P1476>	"Multicenter, Openlabel, Phase II Intergroups (GELTAMO/GETH) Trial, on the Use of Alemtuzumab for Unrelated Donor Reduced Intensity Conditioning Allogenic Transplant in Hematological Malignancies Patients"@en .
<http://www.wikidata.org/entity/statement/Q64710673-EC449AD4-B8EE-4343-9056-18A06A9535F2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Statement> .